Pancreatic Cancer

• CLINICAL_TRIALS research · 2025-04-03
  Clinical Trial Update: Maintenance Chemotherapy With S-1 vs. Observation After Adjuvant Therapy for Resected Pancreatic Cancer With High Risk of Recurrence/Metastasis [Phase 4]

  A Phase 4 clinical trial is evaluating maintenance S-1 chemotherapy versus observation after adjuvant therapy in patients with resected panc…

• CLINICAL_TRIALS research · 2025-04-02
  Clinical Trial Update: Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial) [NA]

  The PeRFormanCe trial is exploring diffusion-weighted MRI, radiomics, and liquid biopsy to predict surgical resectability after FOLFIRINOX i…

• CLINICAL_TRIALS research · 2025-04-01
  Clinical Trial Update: Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer

  Stanford University is running a clinical trial to build a bio-repository of high-risk cohorts for the early detection of pancreatic cancer.…

• CLINICAL_TRIALS research · 2025-03-27
  Clinical Trial Update: Music Therapy in Patients Undergoing Pancreatic Surgery (MUSIC PUPS) [NA]

  The MUSIC PUPS trial evaluates music therapy for postoperative pain management in patients undergoing pancreatic surgery (Whipple procedure …

• CLINICAL_TRIALS research · 2025-03-25
  Clinical Trial Update: Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer [Phase 2]

  A Phase 2 clinical trial is evaluating amplitude-modulated radiofrequency electromagnetic fields for metastatic pancreatic cancer, and the s…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2025-03-25
  Clinical Trial Update: Clinical Study of Carbon Ion Radiotherapy for Pancreatic Cancer. [NA]

  This clinical trial is evaluating carbon ion radiotherapy for pancreatic cancer, including metastatic and non-resectable cases, and is curre…

• CLINICAL_TRIALS research · 2025-03-24
  Clinical Trial Update: Clinical Study of Tumor Treating Fields Combined with Gemcitabine and Albumin-bound Paclitaxel in the First-line Treatment of Locally Advanced Pancreatic Cancer [Phase 3]

  Ongoing Phase 3 clinical trial evaluating the combination of Tumor Treating Fields with gemcitabine and nab-paclitaxel as first-line therapy…

• CLINICAL_TRIALS research · 2025-03-21
  Clinical Trial Update: Personalized Tumor Neoantigen MRNA Therapy Adjuvant Treatment for Postoperative Pancreatic Cancer. [Phase 1, Phase 2]

  Clinical trial update describing a Phase 1/2 study of a personalized tumor neoantigen mRNA therapy used as adjuvant treatment after pancreat…

• CLINICAL_TRIALS research · 2025-03-21
  Clinical Trial Update: Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer [Phase 1]

  A Phase 1 trial of paricalcitol with gemcitabine and nab-paclitaxel in metastatic pancreatic cancer has been terminated.

• CLINICAL_TRIALS research · 2025-03-21
  Clinical Trial Update: Personalized Tumor Neoantigen MRNA Therapy for Advanced Pancreatic Cancer. [Phase 1, Phase 2]

  Phase 1/2 trial of a personalized tumor neoantigen mRNA therapy for advanced pancreatic cancer; study status currently not yet recruiting.

• CLINICAL_TRIALS research · 2025-03-19
  Clinical Trial Update: A Phase I Study of LXP1788 Injection with Advanced Solid Tumors. [Phase 1]

  This Phase I trial is evaluating the safety and tolerability of LXP1788 Injection in adults with advanced solid tumors and is currently recr…

• CLINICAL_TRIALS research · 2025-03-19
  Clinical Trial Update: AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort

  Clinical trial update for an AI-powered non-contrast CT method to detect pancreatic cancer in opportunistic screening; the study is currentl…

• CLINICAL_TRIALS research · 2025-03-18
  Clinical Trial Update: DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer [Phase 2]

  Phase 2 clinical trial (DOVIPA) evaluating dostarlimab and Vitamin D3 with mFOLFIRINOX for pancreatic cancer; currently recruiting.

• CLINICAL_TRIALS research · 2025-03-11
  Clinical Trial Update: 99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors

  This clinical trial is evaluating a technetium-99m labeled FAP-targeted molecular probe for early tumor diagnosis, and the study is currentl…

• CLINICAL_TRIALS research · 2025-03-11
  Clinical Trial Update: Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]

  Phase 2 clinical trial evaluating gemcitabine hydrochloride and cisplatin with or without veliparib, or veliparib alone, in locally advanced…

• CLINICAL_TRIALS research · 2025-03-11
  Clinical Trial Update: Neoadjuvant Chemotherapy for Elderly with Pancreatic Head Cancer

  This clinical trial update describes a neoadjuvant chemotherapy study for elderly patients with pancreatic head cancer that is resectable or…

• CLINICAL_TRIALS research · 2025-03-11
  Clinical Trial Update: A Study of JMT203 in Patients With Cancer Cachexia [Phase 1]

  Phase 1 trial evaluating JMT203 in cancer cachexia, including colorectal cancer and non-small cell lung cancer (also mentioning pancreatic c…

• CLINICAL_TRIALS research · 2025-03-11
  Clinical Trial Update: Prognostic Role of Circulating Tumor DNA in Resectable Pancreatic Cancer

  The document describes a clinical trial evaluating whether circulating tumor DNA can serve as a prognostic biomarker in resectable pancreati…

• CLINICAL_TRIALS research · 2025-03-11
  Clinical Trial Update: Endoscopic Radiofrequency Ablation of Celiac Ganglion for Pain Management and Improvement of Quality of Life in Patients With Unresectable Pancreatic Cancer

  This clinical trial is evaluating endoscopic radiofrequency ablation of the celiac ganglion to manage pain and improve quality of life in pa…

• CLINICAL_TRIALS research · 2025-03-10
  Clinical Trial Update: MRD in PAAD Adjuvant Therapy [NA]

  This clinical trial update indicates an ongoing study at Peking Union Medical College Hospital evaluating the role of molecular residual dis…

• CLINICAL_TRIALS research · 2025-03-10
  Clinical Trial Update: A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic Cancer [Phase 1, Phase 2]

  This is a single-arm, open-label Phase 1/Phase 2 clinical study evaluating the combination of VRT106 with chemotherapy for advanced pancreat…

• CLINICAL_TRIALS research · 2025-03-10
  Clinical Trial Update: Evaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient with Pancreatic Cancer [Phase 1, Phase 2]

  An ongoing Phase 1/Phase 2 clinical trial assessing the safety and efficacy of BEY1107 in combination with gemcitabine for locally advanced …

• CLINICAL_TRIALS research · 2025-03-05
  Clinical Trial Update: IMPact of AerobiC Exercise in Addition to Nutritional Treatment on Quality of Life After Pancreatectomy [NA]

  A clinical trial evaluating whether aerobic exercise added to nutritional treatment improves quality of life after pancreatectomy; the study…

• CLINICAL_TRIALS research · 2025-03-03
  Clinical Trial Update: Lidocaine Infusion in Pancreatic Cancer [EARLY_Phase 1]

  This entry reports an early Phase 1 clinical trial evaluating lidocaine infusion for pancreatic cancer, currently recruiting.

• CLINICAL_TRIALS research · 2025-02-28
  Clinical Trial Update: Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy as an Adjuvant Therapy for Pancreatic Cancer [Phase 1]

  This Phase 1 clinical trial evaluates a neoantigen vaccine plus anti-PD1 therapy and chemotherapy as adjuvant treatment for pancreatic cance…